Moderna shares pop 7% after Cowen upgrades stock, saying it 'will be a leader' in RSV vaccines
March 13, 2023 at 17:01 PM EDT
Moderna shares closed nearly 7% after TD Cowen upgraded the stock, saying the company will "be a leader" in the RSV vaccine market.
